TimesSquare Capital Management LLC Takes Position in Astera Labs, Inc. $ALAB

TimesSquare Capital Management LLC bought a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) during the second quarter, HoldingsChannel.com reports. The firm bought 175,869 shares of the company’s stock, valued at approximately $84,948,000. Astera Labs comprises about 1.2% of TimesSquare Capital Management LLC’s portfolio, making the stock its 21st biggest position.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Glenmede Trust Co. NA grew its position in Astera Labs by 2.7% during the first quarter. Glenmede Trust Co. NA now owns 1,909 shares of the company’s stock valued at $209,000 after acquiring an additional 51 shares during the period. Lido Advisors LLC increased its position in Astera Labs by 0.5% during the 4th quarter. Lido Advisors LLC now owns 12,297 shares of the company’s stock worth $2,046,000 after purchasing an additional 57 shares in the last quarter. Goldstein Advisors LLC increased its position in Astera Labs by 5.8% during the 4th quarter. Goldstein Advisors LLC now owns 1,611 shares of the company’s stock worth $268,000 after purchasing an additional 88 shares in the last quarter. Bell Investment Advisors Inc purchased a new position in Astera Labs in the second quarter valued at approximately $43,000. Finally, Great Valley Advisor Group Inc. increased its position in shares of Astera Labs by 2.2% in the second quarter. Great Valley Advisor Group Inc. now owns 4,119 shares of the company’s stock worth $372,000 after acquiring an additional 90 shares in the last quarter. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Insider Activity at Astera Labs

In related news, Director Manuel Alba sold 136,974 shares of the business’s stock in a transaction dated Wednesday, July 1st. The stock was sold at an average price of $442.01, for a total value of $60,543,877.74. Following the completion of the sale, the director directly owned 1,287,524 shares of the company’s stock, valued at $569,098,483.24. The trade was a 9.62% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Bethany Mayer sold 686 shares of the company’s stock in a transaction that occurred on Wednesday, June 24th. The shares were sold at an average price of $395.04, for a total value of $270,997.44. Following the sale, the director owned 5,550 shares in the company, valued at $2,192,472. The trade was a 11.00% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 631,979 shares of company stock worth $215,479,247. Company insiders own 10.40% of the company’s stock.

Astera Labs Trading Down 0.4%

ALAB stock opened at $320.17 on Tuesday. Astera Labs, Inc. has a twelve month low of $97.89 and a twelve month high of $499.48. The company has a market capitalization of $55.55 billion, a P/E ratio of 158.50 and a beta of 3.84. The firm has a 50 day simple moving average of $357.48 and a 200-day simple moving average of $241.79.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The firm had revenue of $392.40 million for the quarter, compared to analysts’ expectations of $360.85 million. During the same period in the prior year, the company posted $0.44 earnings per share. The firm’s quarterly revenue was up 104.5% on a year-over-year basis. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, research analysts predict that Astera Labs, Inc. will post 2.7 EPS for the current year.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on ALAB shares. Zacks Research raised shares of Astera Labs from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, August 11th. JPMorgan Chase & Co. upped their target price on Astera Labs from $205.00 to $280.00 and gave the stock an “overweight” rating in a research report on Wednesday, May 6th. Bank of America raised their target price on Astera Labs from $240.00 to $450.00 and gave the company a “neutral” rating in a report on Tuesday, June 23rd. Morgan Stanley upped their price target on Astera Labs to $335.00 and gave the stock an “overweight” rating in a report on Monday, August 3rd. Finally, Susquehanna lifted their price objective on shares of Astera Labs from $230.00 to $275.00 and gave the company a “neutral” rating in a research note on Friday, July 31st. One research analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and eight have issued a Hold rating to the company. Based on data from MarketBeat, Astera Labs presently has an average rating of “Moderate Buy” and a consensus target price of $333.00.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.